加拿大和萨斯喀彻温同意40M交易,以增加稀有疾病药物的获得。 Canada and Saskatchewan agree on $40M deal to enhance access to drugs for rare diseases.

加拿大联邦政府和萨斯喀彻温省签署了一项4 000万美元的协议,以改善稀有疾病的药品供应。 The Canadian federal government and Saskatchewan have signed a $40 million deal to improve access to drugs for rare diseases. 该协议涵盖治疗癌症和尿道病的三种特定药物,提高了覆盖率和获得高成本药物的机会。 The agreement covers three specific drugs treating cancers and a urinary condition, enhancing coverage and access to high-cost medications. 这是更好地筛选和诊断罕见疾病的国家战略的一部分,萨斯喀彻温省是加入这一倡议的第四个省份。 This is part of a national strategy to better screen and diagnose rare diseases, with Saskatchewan being the fourth province to join the initiative.